Chemotherapy use end-of-life care and costs of care among patients diagnosed with Stage IV pancreatic cancer

摘要

ContextFor patients with metastatic cancer and limited life-expectancy, potential benefits of chemotherapy must be balanced against harms to quality-of-life near death and increased out-of-pocket costs of care.